Abstract:figure legend Auditory outer hair cells are the cochlear amplifier essential for normal hearing sensitivity and frequency selectivity. This study used both cell lines and a mouse model to define the pathogenic role of compound heterozygous p.W70X (c.209G>A) and p.R130S (c.390A>C) SLC26A5 variants identified in patients with moderate to profound hearing loss. We found that the p.W70X nonsense variant results in a null prestin allele, and that mice carrying one copy of p.R130S (Slc26a5R130S/‐) as in human patients (SLC26A5W70X/R130S) suffer from congenital hearing loss and subsequent premature outer hair cell loss. The latter are both ascribed to slowed motor function of p.R130S prestin, as demonstrated in our preceding studies. Given the recessive nature of prestin‐associated hearing loss, DFNB61, this study points to the presence of a therapeutic time window for potential clinical interventions targeting the affected OHCs before they are lost. DFNB61 is a recessively inherited nonsyndromic hearing loss caused by mutations in SLC26A5, the gene that encodes the voltage‐driven motor protein, prestin. Prestin is abundantly expressed in the auditory outer hair cells that mediate cochlear amplification. Two DFNB61‐associated SLC26A5 variants, p.W70X and p.R130S, were identified in patients who are compound heterozygous for these nonsense and missense changes (SLC26A5W70X/R130S). Our recent study showed that mice homozygous for p.R130S (Slc26a5R130S/R130S) suffer from hearing loss that is ascribed to significantly reduced motor kinetics of prestin. Given that W70X‐prestin is nonfunctional, compound heterozygous Slc26a5R130S/− mice were used as a model for human SLC26A5W70X/R130S. By examining the pathophysiological consequences of p.R130S prestin when it is the sole allele for prestin protein production, we determined that this missense change results in progressive outer hair cell loss in addition to its effects on prestin's motor action. Thus, this study defines the pathogenic roles of p.R130S prestin and identifies a limited time window for potential clinical intervention. Key points The voltage‐driven motor protein, prestin, is encoded by SLC26A5 and expressed abundantly in cochlear outer hair cells (OHCs). The importance of prestin for normal hearing was demonstrated in mice lacking prestin; however, none of the specific SLC26A5 variants identified to date in human patients has been experimentally demonstrated to be pathogenic. In this study we used both cell lines and a mouse model to define the pathogenic role of compound heterozygous p.W70X (c.209G>A) and p.R130S (c.390A>C) SLC26A5 variants identified in patients with moderate to profound hearing loss. As in patients, mice carrying one copy of p.R130S Slc26a5 showed OHC dysfunction and progressive degeneration, which results in congenital progressive hearing loss. This is the first functional study reporting pathogenic SLC26A5 variants and pointing to the presence of a therapeutic time window for potential clinical interventions targeting the affected OHCs before they are lost.

Abnormal Mrna Splicing but Normal Auditory Brainstem Response (ABR) in Mice with the Prestin (SLC26A5) IVS2-2A>G Mutation.

A Novel Mutation Located in the N-Terminal Domain of MYO15A Caused Sensorineural Hearing Loss.

Insights into phenotypic differences between humans and mice with p.T721M and other C-terminal variants of the SLC26A4 gene

Genetic Correction of TRMU Allele Restored the Mitochondrial Dysfunction-Induced Deficiencies in Ipscs-Derived Hair Cells of Hearing-Impaired Patients.

Toward the Pathogenicity of the SLC26A4 p.C565Y Variant Using a Genetically Driven Mouse Model

The pathogenic roles of the p.R130S prestin variant in DFNB61 hearing loss

CRISPR/Cas9-mediated exon skipping to restore premature translation termination in a DFNB4 mouse model

The frequency dependence of prestin-mediated fast electromotility for mammalian cochlear amplification

Slc26a4-insufficiency Causes Fluctuating Hearing Loss and Stria Vascularis Dysfunction

Targeted expression of <i>SLC26A4</i> rescues hearing and balance in <i>Slc26a4</i> <i> <sup>Δ/Δ</sup> </i> mice

SLC26A4 Targeted to the Endolymphatic Sac Rescues Hearing and Balance in Slc26a4 Mutant Mice.

A Mutation in the Srrm4 Gene Causes Alternative Splicing Defects and Deafness in the Bronx Waltzer Mouse

Two new mouse alleles of Ocm and Slc26a5

A New Mutation of Sgms1 Causes Gradual Hearing Loss Associated with a Reduced Endocochlear Potential

Transcriptomic Analysis Reveals an Altered Hcy Metabolism in the Stria Vascularis of the Pendred Syndrome Mouse Model

Mouse model of enlarged vestibular aqueducts defines temporal requirement of Slc26a4 expression for hearing acquisition.

Phenotypic differences in the inner ears of CBA/CaJ and C57BL/6J mice carrying missense and single base pair deletion mutations in the Cdh23 gene

SMPX Deficiency Causes Stereocilia Degeneration and Progressive Hearing Loss in CBA/CaJ Mice

Rescue of Mis-Splicing of a Common SLC26A4 Mutant Associated with Sensorineural Hearing Loss by Antisense Oligonucleotides.

Abnormal Innervation, Demyelination, and Degeneration of Spiral Ganglion Neurons as Well as Disruption of Heminodes are Involved in the Onset of Deafness in Cx26 Null Mice

Deletion of a Long-Range Dlx5 Enhancer Disrupts Inner Ear Development in Mice